RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @ester0961: ATENCIÓ 🔴 En pacients amb Covid es produeixen respostes inflamatòries greus. Tocilizumab, com a anticòs monoclonal del rec…
RT @ester0961: ATENCIÓ 🔴 En pacients amb Covid es produeixen respostes inflamatòries greus. Tocilizumab, com a anticòs monoclonal del rec…
RT @ShorterLab: Effective treatment of severe COVID-19 patients with tocilizumab https://t.co/HZ47HUmcWg
RT @ester0961: ATENCIÓ 🔴 En pacients amb Covid es produeixen respostes inflamatòries greus. Tocilizumab, com a anticòs monoclonal del rec…
RT @ester0961: ATENCIÓ 🔴 En pacients amb Covid es produeixen respostes inflamatòries greus. Tocilizumab, com a anticòs monoclonal del rec…
RT @ester0961: ATENCIÓ 🔴 En pacients amb Covid es produeixen respostes inflamatòries greus. Tocilizumab, com a anticòs monoclonal del rec…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @ester0961: ATENCIÓ 🔴 En pacients amb Covid es produeixen respostes inflamatòries greus. Tocilizumab, com a anticòs monoclonal del rec…
ATENCIÓ 🔴 En pacients amb Covid es produeixen respostes inflamatòries greus. Tocilizumab, com a anticòs monoclonal del receptor anti-IL-6 humà pot ser capaç de bloquejar el dany immune a les cèl·lules diana, i alleujar les respostes inflamatòries. https
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @jonathanrockoff: BREAKING: $RHHBY's Actemra showed signs of helping treat severe Covid-19 patients, according to this @PNASNews study j…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
here it is effective but again no control to compare placebo. Effective treatment of severe COVID-19 patients with tocilizumab | PNAS https://t.co/XDFn8d46TL
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @jonathanrockoff: BREAKING: $RHHBY's Actemra showed signs of helping treat severe Covid-19 patients, according to this @PNASNews study j…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @jonathanrockoff: BREAKING: $RHHBY's Actemra showed signs of helping treat severe Covid-19 patients, according to this @PNASNews study j…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medicament és Tocilizumab,un anticòs monoclonal que bloqueja les cèl·lules que sobrereaccionen i generen una resposta inflamatòria fora mida
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
cc: @Gargotejant
RT @MarceloNLeite: Vc já ouviu falar do anticorpo monoclonal tocilizumabe aqui: https://t.co/Vr5nRM2C9M https://t.co/FiQRGzVGNy
Long $RHHBY ....
RT @jonathanrockoff: BREAKING: $RHHBY's Actemra showed signs of helping treat severe Covid-19 patients, according to this @PNASNews study j…
Otro pequeño estudio a favor del tocilizumab https://t.co/CEGYPbJUCz Resultados preliminares publicados en PNAS, mirá @EzequielZaidel
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @MarceloNLeite: Vc já ouviu falar do anticorpo monoclonal tocilizumabe aqui: https://t.co/Vr5nRM2C9M https://t.co/FiQRGzVGNy
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @jonathanrockoff: BREAKING: $RHHBY's Actemra showed signs of helping treat severe Covid-19 patients, according to this @PNASNews study j…
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
Vc já ouviu falar do anticorpo monoclonal tocilizumabe aqui: https://t.co/Vr5nRM2C9M https://t.co/FiQRGzVGNy
yep not new, as pointed out by @BiotechObserver preprint available here (1 month ago) https://t.co/hZVfxA7zoW
RT @Blacklace40: So Tocilizumab (antibody treatment) binds to receptors on cytokines (inflammatory proteins that signal other cells). COVID…
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @jonathanrockoff: BREAKING: $RHHBY's Actemra showed signs of helping treat severe Covid-19 patients, according to this @PNASNews study j…
RT @sciencescanner: Somewhat encouraging - but as its not placebo-controlled, and given the failure of Kevzara, I would be surprised if thi…
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @Blacklace40: So Tocilizumab (antibody treatment) binds to receptors on cytokines (inflammatory proteins that signal other cells). COVID…
Somewhat encouraging - but as its not placebo-controlled, and given the failure of Kevzara, I would be surprised if this modest efficacy with tocilizumab was replicated in a larger RCT $RHHBY
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
So Tocilizumab (antibody treatment) binds to receptors on cytokines (inflammatory proteins that signal other cells). COVID causes "cytokine storms" producing a severe inflammatory response. Tocilizumab prevents cytokines from sending messages, thus reducin
RT @greg_folkers: .@PNASNews PNAS: Effective treatment of severe #COVID19 patients with tocilizumab https://t.co/6fSuvMQL7T
Anyone heard of this? https://t.co/9wX7k90DkS
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @jonathanrockoff: BREAKING: $RHHBY's Actemra showed signs of helping treat severe Covid-19 patients, according to this @PNASNews study j…
21 patients though
RT @greg_folkers: .@PNASNews PNAS: Effective treatment of severe #COVID19 patients with tocilizumab https://t.co/6fSuvMQL7T
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @jonathanrockoff: BREAKING: $RHHBY's Actemra showed signs of helping treat severe Covid-19 patients, according to this @PNASNews study j…
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @jonathanrockoff: BREAKING: $RHHBY's Actemra showed signs of helping treat severe Covid-19 patients, according to this @PNASNews study j…
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @jonathanrockoff: BREAKING: $RHHBY's Actemra showed signs of helping treat severe Covid-19 patients, according to this @PNASNews study j…
RT @jonathanrockoff: BREAKING: $RHHBY's Actemra showed signs of helping treat severe Covid-19 patients, according to this @PNASNews study j…
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
BREAKING: $RHHBY's Actemra showed signs of helping treat severe Covid-19 patients, according to this @PNASNews study just posted. https://t.co/AhW4okG9SF
RT @ShorterLab: Effective treatment of severe COVID-19 patients with tocilizumab https://t.co/HZ47HUmcWg
.@PNASNews PNAS: Effective treatment of severe #COVID19 patients with tocilizumab https://t.co/6fSuvMQL7T
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
FYI... no way in HELL I would ever get a Chinese made vaccine. If that is what they push I'm out.
Effective treatment of severe COVID-19 patients with tocilizumab https://t.co/48jc8bM8xh @realdonaldtrump #coronavirus @cdcgov
Effective treatment of severe #COVID19 patients with tocilizumab | PNAS https://t.co/5FgbWv9ZKD
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
PNAS. https://t.co/gwwOZvkWtV
Effective treatment of severe COVID-19 patients with tocilizumab https://t.co/HZ47HUmcWg